FMP

FMP

Enter

HRMY - Harmony Bi...

photo-url-https://images.financialmodelingprep.com/symbol/HRMY.png

Harmony Biosciences Holdings, Inc.

HRMY

NASDAQ

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.

32.72 USD

0 (0%)

Build Up Free Cash Flow

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Revenue

2.76B

1.76B

1.57B

1.39B

1.38B

1.18B

1B

853.43M

727.07M

619.42M

Operating Cash Flow

134.53M

19.82M

-133.01M

76.93M

62.37M

17.84M

15.2M

12.95M

11.03M

9.4M

Cap Ex

-33.71M

-36.27M

-27.65M

-23.55M

-23.6M

-19.87M

-16.93M

-14.42M

-12.29M

-10.47M

Free Cash Flow

100.82M

-16.45M

-160.66M

53.38M

38.77M

-2.03M

-1.73M

-1.47M

-1.26M

-1.07M

Wacc

9.25

9.25

9.25

9.25

9.25

Pv Lfcf

-1.86M

-1.45M

-1.13M

-881.81k

-687.64k

Sum Pv Lfcf

-6.01M

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep